Proactive financial news and online broadcast teams provide fast, accessible, informative and actionable business and finance news content to a global investment audience. All our content is ...
Arecor Therapeutics PLC (AIM:AREC) CEO Sarah Howell speaks to Thomas Warner from Proactive after the globally-focused biopharmaceutical group released its interim results for the six months to 30 June ...
With that in mind, let's look at a rising star in the biotech industry: CRISPR Therapeutics (NASDAQ: CRSP). How do the company's prospects look for the next half-decade? CRISPR Therapeutics is a ...
SAN FRANCISCO--(BUSINESS WIRE)--Rezo Therapeutics, a biotechnology company pioneering the integrated mapping of disease networks for precision therapeutics, today announced the appointment of ...
Regulus Therapeutics Inc RGLS released topline results from the first cohort of patients in its Phase 1b Multiple-Ascending Dose (MAD) trial of RGLS8429 for Autosomal Dominant Polycystic Kidney ...
C4X Discovery (C4XD), a drug development company with a leading technology for rational drug discovery and design has successfully floated on the AIM market of the London Stock Exchange with ...
It is doubtless a positive to see that the C4X Discovery Holdings plc ( LON:C4XD ) share price has gained some 39% in... Simply Wall St. We can readily understand why investors are attracted to ...
It is doubtless a positive to see that the C4X Discovery Holdings plc ( LON:C4XD ) share price has gained some 39% in... Simply Wall St. We can readily understand why investors are attracted to ...
Stocks: Real-time U.S. stock quotes reflect trades reported through Nasdaq only; comprehensive quotes and volume reflect trading in all markets and are delayed at least 15 minutes. International ...
Half-year Report for the six months ended 30 June 2023 4basebio PLC (AIM: 4BB), Cambridge, UK, 21 September 2023 - 4basebio PLC, an innovation driven biotechnology company enabling and accelerating ...
The organization is proud to announce its 2024 recipients, who will receive their award or honor at the 104th AMS Annual Meeting in Baltimore, Maryland, 28 January–1 February, 2024.
HOWARD - A Madison-based developer's mixed-use plan for the former AMS campus in Howard includes more than 1,300 apartments, a parking garage, four potential office buildings, two retail buildings ...
Given the high cost of bringing life science products to market, raising funds is especially challenging in the biotechnology sector. Being well prepared for the initial financing round will make ...
London South East prides itself on its community spirit, and in order to keep the chat section problem free, we ask all members to follow these simple rules. In these rules, we refer to ourselves ...
London South East prides itself on its community spirit, and in order to keep the chat section problem free, we ask all members to follow these simple rules. In these rules, we refer to ourselves ...
York-headquartered life sciences company Aptamer Group has completed a six-figure fundraise. The listed company has raised £310,772 through the issue of about 28.3 million new ordinary shares by way ...
The drug is the second RNA aptamer to gain FDA approval, and the second complement-targeted drug for this cause of blindness. Avacincaptad pegol could be a turning point. “Perceptions can change ...
London South East prides itself on its community spirit, and in order to keep the chat section problem free, we ask all members to follow these simple rules. In these rules, we refer to ourselves ...
London South East prides itself on its community spirit, and in order to keep the chat section problem free, we ask all members to follow these simple rules. In these rules, we refer to ourselves ...
Global 99 Pages Updated Report of "Recombinant Antibody Market" research report provides the latest information about prominent global key players (Abnova , Medix Biochemica , GE Healthcare ...